ReviewESC heart failure2018
Rationale and design of the randomized multicentre His Optimized Pacing Evaluated for Heart Failure (HOPE-HF) trial.
Review in ESC heart failure, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Effects of haemodynamically atrio-ventricular optimized His bundle pacing on heart failure symptoms and exercise capacity: the His Optimized Pacing Evaluated for Heart Failure (HOPE-HF) randomized, double-blind, cross-over trial.European journal of heart failure · 2023Trial
- Prevalence and incidence of left ventricular systolic dysfunction and adverse outcomes in patients receivingEuropean heart journal open · 2026Article
- Conduction system pacing: how far are we from the "electrical" bypass?Heart failure reviews · 2024Review
- Prolonged PR interval and incidence of atrial fibrillation, heart failure admissions, and mortality in patients with implanted cardiac devices: A real-world survey.Heart rhythm O2 · 2023Article
- Left bundle branch area pacing in patients with heart failure and right bundle branch block: Results from International LBBAP Collaborative-Study Group.Heart rhythm O2 · 2022Article
- Innovations in Cardiac Implantable Electronic Devices.Cardiovascular drugs and therapy · 2022Review
- Iatrogenic pacemaker-induced ventricular arrhythmia: a case report.European heart journal. Case reports · 2022Article
- Optimizing atrio-ventricular delay in pacemakers using potentially implantable physiological biomarkers.Pacing and clinical electrophysiology : PACE · 2022Article
- Alternative pacing strategies for optimal cardiac resynchronization therapy.Frontiers in cardiovascular medicine · 2022Review
- Electrocardiographic predictors of successful resynchronization of left bundle branch block by His bundle pacing.Journal of cardiovascular electrophysiology · 2021Article
- His-Purkinje Conduction System Pacing: State of the Art in 2020.Arrhythmia & electrophysiology review · 2020Review
- The Emerging Role of Cardiac Conduction System Pacing as a Treatment for Heart Failure.Current heart failure reports · 2020Review
- [Indications for His bundle and left bundle branch pacing].Herzschrittmachertherapie & Elektrophysiologie · 2020Review
- The difference in referencing in Web of Science, Scopus, and Google Scholar.ESC heart failure · 2019Article
- His bundle pacing, learning curve, procedure characteristics, safety, and feasibility: Insights from a large international observational study.Journal of cardiovascular electrophysiology · 2019Observational
- Improving Cardiac Resynchronisation Therapy.Arrhythmia & electrophysiology review · 2019Review
- His Bundle Pacing: A New Strategy for Physiological Ventricular Activation.Journal of the American Heart Association · 2019Review
- Device Programming for His Bundle Pacing.Circulation. Arrhythmia and electrophysiology · 2019Review
- Adverse Consequences of Right Ventricular Apical Pacing and Novel Strategies to Optimize Left Ventricular Systolic and Diastolic Function.Current cardiology reviews · 2019Review
- His Resynchronization Versus Biventricular Pacing in Patients With Heart Failure and Left Bundle Branch Block.Journal of the American College of Cardiology · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
aimsIn patients with heart failure and a pathologically prolonged PR interval, left ventricular (LV) filling can be improved by shortening atrioventricular delay using His-bundle pacing. His-bundle pacing delivers physiological ventricular activation and has been shown to improve acute haemodynamic function in this group of patients. In the HOPE-HF (His Optimized Pacing Evaluated for Heart Failure) trial, we are investigating whether these acute haemodynamic improvements translate into improvements in exercise capacity and heart failure symptoms. METHODS AND
resultsThis multicentre, double-blind, randomized, crossover study aims to randomize 160 patients with PR prolongation (≥200 ms), LV impairment (EF ≤ 40%), and either narrow QRS (≤140 ms) or right bundle branch block. All patients receive a cardiac device with leads positioned in the right atrium and the His bundle. Eligible patients also receive a defibrillator lead. Those not eligible for implantable cardioverter defibrillator have a backup pacing lead positioned in an LV branch of the coronary sinus. Patients are allocated in random order to 6 months of (i) haemodynamically optimized dual chamber His-bundle pacing and (ii) backup pacing only, using the non-His ventricular lead. The primary endpoint is change in exercise capacity assessed by peak oxygen uptake. Secondary endpoints include change in ejection fraction, quality of life scores, B-type natriuretic peptide, daily patient activity levels, and safety and feasibility assessments of His-bundle pacing.
conclusionsHope-HF aims to determine whether correcting PR prolongation in patients with heart failure and narrow QRS or right bundle branch block using haemodynamically optimized dual chamber His-bundle pacing improves exercise capacity and symptoms. We aim to complete recruitment by the end of 2018 and report in 2020.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.